Literature DB >> 15459404

Liquid based cytology: examination of its potential in a chlamydia screening programme.

J Hopwood1, H Mallinson, E Hodgson, L Hull.   

Abstract

OBJECTIVE: To assess the feasibility of testing for chlamydia directly on a single liquid based specimen (ThinPrep test) collected for cervical screening.
METHOD: Cervical smears were taken using a Cervex spatula and rinsed in the liquid based cytology collection vial. Following this, the conventional sample for chlamydia testing was taken from the endocervix using an Abbott Collection kit. Cytological specimens were prepared using an automated slide processor. Residual cellular material and the conventional samples were sent to the laboratory where both were tested for chlamydia by ligase chain reaction (LCR). The manufacturer's protocol for LCR urine testing was modified to substitute 1 ml of PreservCyt suspension.
RESULTS: 581 women had both swab and cytology suspension tested for Chlamydia trachomatis with LCR. There were 19 concordant positive and 562 concordant negative reports. The stability of chlamydia in the cytology suspension was maintained for at least 5 months.
CONCLUSION: The findings lead us to conclude that samples collected for liquid based cytology using the ThinPrep test collection vial provide a potential platform for chlamydia screening, though the study established several issues to be addressed to make this a practical proposition.

Entities:  

Mesh:

Year:  2004        PMID: 15459404      PMCID: PMC1744897          DOI: 10.1136/sti.2003.008359

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  9 in total

1.  Performance of a fluid-based, thin-layer papanicolaou smear method in the clinical setting of an independent laboratory and an outpatient screening population in New England.

Authors:  L A Díaz-Rosario; S E Kabawat
Journal:  Arch Pathol Lab Med       Date:  1999-09       Impact factor: 5.534

2.  Molecular Papanicolaou tests in the twenty-first century: molecular analyses with fluid-based Papanicolaou technology.

Authors:  W M Lin; R Ashfaq; E A Michalopulos; A Maitra; A F Gazdar; C Y Muller
Journal:  Am J Obstet Gynecol       Date:  2000-07       Impact factor: 8.661

3.  Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy.

Authors:  S J Bernstein; L Sanchez-Ramos; B Ndubisi
Journal:  Am J Obstet Gynecol       Date:  2001-08       Impact factor: 8.661

4.  Resolution of the recent performance problem of Abbott LCx Chlamydia trachomatis assay. Issues of repeat testing for confirmation of chlamydial infection.

Authors:  H Mallinson; J Hopwood; K Mutton
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

5.  Comparison of conventional Papanicolaou smears and a fluid-based, thin-layer system for cervical cancer screening.

Authors:  K R Lee; R Ashfaq; G G Birdsong; M E Corkill; K M McIntosh; S L Inhorn
Journal:  Obstet Gynecol       Date:  1997-08       Impact factor: 7.661

6.  Chlamydia trachomatis and Pap testing from a single, fluid-based sample. A multicenter study.

Authors:  S L Inhorn; P J Wand; T C Wright; K D Hatch; J Hallum; B B Lentrichia
Journal:  J Reprod Med       Date:  2001-03       Impact factor: 0.142

7.  Efficacy of a liquid-based thin layer method for cervical cancer screening in a population with a low incidence of cervical cancer.

Authors:  J Weintraub; A Morabia
Journal:  Diagn Cytopathol       Date:  2000-01       Impact factor: 1.582

8.  Rapid detection of HSV from cytologic specimens collected into ThinPrep fixative.

Authors:  M D Fiel-Gan; C F Villamil; S R Mandavilli; M E Ludwig; G J Tsongalis
Journal:  Acta Cytol       Date:  1999 Nov-Dec       Impact factor: 2.319

9.  PreservCyt transport medium used for the ThinPrep Pap test is a suitable medium for detection of Chlamydia trachomatis by the COBAS Amplicor CT/NG test: results of a preliminary study and future implications.

Authors:  Anne Bianchi; François Moret; Jean-Marc Desrues; Thierry Champenois; Yves Dervaux; Orlane Desvouas; André Oursin; Dominique Quinzat; Roger Dachez; Christian Bathelier; Christophe Ronsin
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

  9 in total
  3 in total

1.  APTIMA assay on SurePath liquid-based cervical samples compared to endocervical swab samples facilitated by a real time database.

Authors:  Samer N Khader; Kathie Schlesinger; Josh Grossman; Richard I Henry; Mark Suhrland; Amy S Fox
Journal:  Cytojournal       Date:  2010-07-02       Impact factor: 2.091

2.  Abilities of APTIMA, AMPLICOR, and ProbeTec assays to detect Chlamydia trachomatis and Neisseria gonorrhoeae in PreservCyt ThinPrep Liquid-based Pap samples.

Authors:  M Chernesky; D Jang; E Portillo; S Chong; M Smieja; K Luinstra; A Petrich; C Macritchie; R Ewert; B Hayhoe; A Sarabia; F Thompson
Journal:  J Clin Microbiol       Date:  2007-05-30       Impact factor: 5.948

3.  Detection of Chlamydia trachomatis and Neisseria gonorrhoeae infections in North American women by testing SurePath liquid-based Pap specimens in APTIMA assays.

Authors:  Max Chernesky; Gregory G Freund; Edward Hook; Peter Leone; Peter D'Ascoli; Mark Martens
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.